IL26 and Alzheimer disease: Additionally, IL-26 administration aggravates oxazolone-induced AD in mice via the promotion of the Th2 and Th17 response and increases mortality in mouse models of sepsis, accompanied by increased infiltration of neutrophils into the peritoneal cavity (8, 16).